| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $735.8M | $715.1M | $728.7M |
| YoY Revenue Growth % | +2.9% | -1.9% | — |
| Gross Profit | $475.0M | $485.3M | — |
| Gross Margin % | 64.6% | 67.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $18.9M | $15.2M | -$27.6M |
| Operating Margin % | 2.6% | 2.1% | -3.8% |
| Net Income (GAAP) | $1.6M | -$27.2M | -$67.6M |
| EBITDA (Normalized) | $21.9M | $17.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $55.8M | $63.6M | $79.0M |
| Capital Expenditures (CapEx) | $3.7M | $2.4M | — |
| Free Cash Flow (FCF) | $52.1M | $61.2M | $79.0M |
| FCF Margin % | 7.1% | 8.6% | 10.8% |
| Return on Invested Capital (ROIC %) | 4.3% | 3.4% | — |
| Cash & Short-Term Equivalents | $86.9M | $104.2M | — |
| Total Debt (Short + Long Term) | $294.5M | $348.0M | — |
| Total Stockholders' Equity | $142.9M | $113.0M | — |